Gabriel Blatner

Gabriel joined Health Advances in 2023 and brings experience in medical technology and biopharma with a focus on market access and M&A. 

Prior to joining Health Advances, Gabriel was a Research Assistant at Brandeis University, and a Fellow on the Investment Team at T.Rx Venture Capital. 

Gabriel graduated Phi Beta Kappa with a BA in Neuroscience from Brandeis University.